nan
Artificial intelligence (AI) In Hospital Operation Market Value Expansion And Long-Term Growth Outlook
The market size for the electronic quality management system (EQMS) for pharma and medtech has experienced swift expansion recently. This market is anticipated to expand from $2.9 billion in 2025 to $3.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.8%. The growth witnessed in the past can be attributed to various factors such as increased regulatory scrutiny on quality and compliance processes, the growing adoption of digital quality documentation systems, an escalating requirement for standardized CAPA management practices, an expanding emphasis on audit preparedness and inspection readiness, and a heightened demand for end-to-end quality process visibility.
The market size for electronic quality management systems (EQMS) within the pharmaceutical and medical technology sectors is anticipated to experience swift expansion over the upcoming years. This market is projected to reach $5.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. Several factors will drive this expansion during the forecast period, including the increasing integration of cloud-based EQMS platforms within life sciences organizations, greater financial commitment to predictive quality and risk management functionalities, a heightened need for combined supplier quality management solutions, broader deployment of automated compliance monitoring frameworks, and an intensified emphasis on developing scalable quality management systems for international operations. Key trends anticipated during this period encompass the wider acceptance of centralized platforms for managing quality events, the increasing application of automated CAPA workflows for effective compliance oversight, a rising requirement for digital systems controlling documents and their versions, a broadening utilization of audit management tools to enhance preparedness for regulations, and a heightened commitment to tracking employee training and qualifications within regulated settings.
Download A Free Sample Report For Comprehensive Market Insights:
Electronic Quality Management System (EQMS) For Pharma And Medtech Market Growth Factors Supporting Long-Term Expansion
The increasing volume of regulatory inspections and audits is anticipated to drive the expansion of the electronic quality management system (EQMS) for pharma and medtech market. These evaluations involve structured assessments conducted by health authorities to verify that pharmaceutical and medical technology organizations comply with established quality and safety standards. The rise in such inspections and audits is attributed to more stringent compliance requirements imposed by health authorities to guarantee product quality, patient safety, and data integrity. An electronic quality management system (EQMS) for pharma and medtech facilitates these processes by centralizing quality records, automating compliance activities, and ensuring rapid access to accurate audit documentation. For instance, in March 2024, the twelfth annual survey from the International Forum of Independent Audit Regulators (IFIAR), a Japan-based organization, revealed an increase in the proportion of listed PIE audits inspected that identified at least one finding across all five inspection areas when compared to their 2022 survey. Thus, the growing number of regulatory inspections and audits is a significant driver for the electronic quality management system (EQMS) for pharma and medtech market.
Artificial intelligence (AI) In Hospital Operation Market Segment Analysis Highlighting Growth Areas
The electronic quality management system (eqms) for pharma and medtech market covered in this report is segmented –
1) By Component: Software; Services
2) By Deployment Mode: On Premises; Cloud Based
3) By Enterprise Size: Small And Medium Enterprises; Large Enterprises
4) By Application: Document Management; Change Management; Corrective And Preventive Action Management; Training Management; Audit Management; Supplier Quality Management; Other Applications
5) By End User: Pharmaceutical Companies; Biotechnology Companies; Medical Device Manufacturers; Other End Users
Subsegments:
1) By Software: Document Control And Management Software; Corrective And Preventive Action Management Software; Audit Management Software; Training And Compliance Management Software; Risk Management And Analytics Software
2) By Services: Implementation And Integration Services; Validation And Compliance Services; Consulting And Advisory Services; Training And Support Services; Maintenance And Upgrade Services
Innovation In AI-Driven Quality And Compliance Automation For Life Sciences
Major companies operating in the electronic quality management system (EQMS) for pharma and medtech market are focusing on developing innovative solutions, such as artificial intelligence (AI)-powered quality management platforms to enhance regulatory compliance, automate documentation workflows, and improve operational efficiency in life sciences organizations. Artificial Intelligence (AI)-powered quality management platforms are digital systems that use machine learning and automation to manage quality assurance and compliance processes, helping pharmaceutical and medtech companies reduce manual errors, streamline documentation, improve regulatory compliance, and accelerate decision-making. For instance, in April 2023, Dot Compliance, an Israel-based provider of compliance and quality management software for life sciences, launched the industry’s first AI-based ChatGPT-powered eQMS for life sciences. The platform integrates embedded generative and predictive artificial intelligence with proprietary algorithms to automate quality management tasks, optimize compliance workflows, and improve reporting accuracy. It enables quality assurance professionals to automate document creation, deviation management, and regulatory reporting while enhancing organizational compliance performance. The solution is designed as a ready-to-use cloud-based platform that supports pharmaceutical and medtech companies in accelerating product development timelines and adapting to evolving regulatory requirements.
Electronic Quality Management System (EQMS) For Pharma And Medtech Market Competitive Landscape And Leading Companies
Major companies operating in the electronic quality management system (eqms) for pharma and medtech market are Oracle Corporation; Siemens AG; Honeywell International Inc.; IQVIA Holdings Inc.; Dassault Systèmes SE; Veeva Systems Inc.; MetricStream Inc.; MasterControl Inc.; ETQ (RPS Inc.); Ideagen plc; PSC Software; Ennov Group; ComplianceQuest Inc.; AmpleLogic Private Limited; AssurX Inc.; Intellect Design Arena Limited; Greenlight Guru LLC; Qualio Technologies Limited; Dot Compliance Ltd.; Scilife NV; QT9 Software Inc.; Omnex Systems LLC; Orcanos Ltd.; ZenQMS LLC; Trackmedium Pty Ltd.; Qualtrax; Pilgrim Quality Solutions
Access The Complete Electronic Quality Management System (EQMS) For Pharma And Medtech Market Report:
Electronic Quality Management System (EQMS) For Pharma And Medtech Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the electronic quality management system (EQMS) for pharma and medtech market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electronic quality management system (EQMS) for pharma and medtech market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.